Immunosuppressive Drugs in the Management of Progressive, Corticosteroid-resistant Uveitis Associated with Juvenile Rheumatoid Arthritis
Overview
Authors
Affiliations
Cassinotti A, Batticciotto A, Parravicini M, Lombardo M, Radice P, Cortelezzi C Therap Adv Gastroenterol. 2022; 15:17562848221085889.
PMID: 35340755 PMC: 8949794. DOI: 10.1177/17562848221085889.
Pharmacotherapy for uveitis: current management and emerging therapy.
Barry R, Nguyen Q, Lee R, Murray P, Denniston A Clin Ophthalmol. 2014; 8:1891-911.
PMID: 25284976 PMC: 4181632. DOI: 10.2147/OPTH.S47778.
Pharmacotherapy of scleritis: current paradigms and future directions.
Beardsley R, Suhler E, Rosenbaum J, Lin P Expert Opin Pharmacother. 2013; 14(4):411-24.
PMID: 23425055 PMC: 3888795. DOI: 10.1517/14656566.2013.772982.
Methotrexate for ocular inflammatory diseases.
Gangaputra S, Newcomb C, Liesegang T, Kacmaz R, Jabs D, Levy-Clarke G Ophthalmology. 2009; 116(11):2188-98.e1.
PMID: 19748676 PMC: 3785935. DOI: 10.1016/j.ophtha.2009.04.020.
The use of low dose methotrexate in children with chronic anterior and intermediate uveitis.
Malik A, Pavesio C Br J Ophthalmol. 2005; 89(7):806-8.
PMID: 15965154 PMC: 1772752. DOI: 10.1136/bjo.2004.054239.